RRC ID 44036
Author Davids MS, Deng J, Wiestner A, Lannutti BJ, Wang L, Wu CJ, Wilson WH, Brown JR, Letai A.
Title Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Journal Blood
Abstract Stroma induces treatment resistance in chronic lymphocytic leukemia (CLL), possibly because of alterations in the BCL-2 family of proteins, which are key regulators of apoptosis. We previously developed BH3 profiling, a functional assay that assesses mitochondrial depolarization in response to BH3-only peptides, to measure "apoptotic priming," the proximity of a cell to the apoptotic threshold. In the present study, we use BH3 profiling to show that CLL cells from the PB are highly primed. Increased priming is associated with improved clinical response and, unexpectedly, with unmutated IGHV status. Coculturing CLL cells in vitro with stroma decreases priming. Using matched PB, BM, and lymph node compartment samples, we found in vivo that BM-derived CLL cells are the least primed. CLL cells cocultured with stroma were treated with the PI3K δ-isoform inhibitor CAL-101 (GS1101). CAL-101 caused CLL cell de-adhesion, leading to increased CLL cell priming. Stimulation of CLL cells with anti-IgM or CXCL12 caused decreased priming that could be reversed by CAL-101. Our results show that inhibition of stromal interactions leading to displacement of CLL cells into the blood by CAL-101 in vivo may increase CLL cell priming, suggesting a mechanism by which agents inducing lymphocyte redistribution might facilitate improved clinical response when used in combination with other therapies.
Volume 120(17)
Pages 3501-9
Published 2012-10-25
DOI 10.1182/blood-2012-02-414060
PII S0006-4971(20)46242-1
PMID 22955911
PMC PMC3482860
MeSH Antibodies, Anti-Idiotypic / pharmacology Apoptosis / drug effects Apoptosis / immunology Bone Marrow Cells / drug effects Bone Marrow Cells / pathology Cell Communication / drug effects Cell Communication / immunology* Chemokine CXCL12 / pharmacology Coculture Techniques Humans Immunoglobulin M / immunology Leukemia, Lymphocytic, Chronic, B-Cell / immunology* Leukemia, Lymphocytic, Chronic, B-Cell / metabolism Leukemia, Lymphocytic, Chronic, B-Cell / pathology Lymph Nodes / drug effects Lymph Nodes / pathology Lymphocytes / drug effects Lymphocytes / immunology* Lymphocytes / pathology Membrane Potential, Mitochondrial / drug effects Membrane Potential, Mitochondrial / immunology Mitochondria / drug effects Mitochondria / immunology* Mitochondria / metabolism Peptide Fragments / pharmacology Phosphatidylinositol 3-Kinases / metabolism Phosphoinositide-3 Kinase Inhibitors Proto-Oncogene Proteins / pharmacology Purines / pharmacology Quinazolinones / pharmacology Signal Transduction / drug effects Signal Transduction / immunology Stromal Cells / drug effects Stromal Cells / immunology* Stromal Cells / pathology Tumor Cells, Cultured
IF 17.794
Times Cited 78
Human and Animal Cells StromaNKtert(RCB2350)